AR

Ashok Rao Tungaturthi

Active Director Director DIN 11429053
DIN 11429053 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashok Rao Tungaturthi

Data last updated:

Ashok Rao Tungaturthi is a Director at Verumor India Private Limited (since 2026) and Designated Partner at Vasparixus Apex Therapeutics Llp (since 2025).

DIN 11429053
Primary Designation Director
First Appointment 15 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Verumor India Private Limited U62010TS2026PTC211283
Director12 Feb 20262026Active
Designated Partner15 Dec 20252025Active

Board colleagues of Ashok Rao Tungaturthi

NameDINCompanyDesignation
Rahul Dhawan07316009Verumor India Private LimitedDirector
Anitha Ashok Thungathurthi11429054Vasparixus Apex Therapeutics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vasparixus Apex Therapeutics Llp
Verumor India Private Limited
Premium access

Shareholding and investment profile for Ashok Rao Tungaturthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Rao Tungaturthi

Ashok Rao Tungaturthi currently holds 2 directorships: Verumor India Private Limited (Director, since 12 Feb 2026); Vasparixus Apex Therapeutics Llp (Designated Partner, since 15 Dec 2025).

Ashok Rao Tungaturthi was first appointed on 15 Dec 2025 as Designated Partner at Vasparixus Apex Therapeutics Llp. The most recent appointment on record is 12 Feb 2026 at Verumor India Private Limited.

The current boards of Ashok Rao Tungaturthi's companies include Rahul Dhawan (Verumor India Private Limited), Anitha Ashok Thungathurthi (Vasparixus Apex Therapeutics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available